A Pilot Study on Knowledge and Experience on use of Generic Medicines among Healthcare Professionals

Author:

Kumar Gupta Vinay1,Singh Amit1,K. Gupta Ajay1,Trigunayat A.1,Kumar B.1

Affiliation:

1. Department of Pharmacology, IMS, BHU, Varanasi.

Abstract

Those medicines which are having same efficacy as that of their branded and expensive counterparts are known as Generic medicines. Compare to branded medicines, generic medicines have similar route of administration, indication, side effects, strength. Contrary to lower price and affordability the generic medicines are not so popular among healthcare professionals. The objective of this study is to analyse, knowledge and experience on use of generic medicines among healthcare professionals. A pilot study was conducted at Institute of Medical Sciences (IMS) Banaras Hindu University Varanasi India. This was a questionnaire-based cross-sectional study. The participants were doctors, nurses, pharmacists and others (research scholars and PG students). Chi square test used to find out p value. The overall response rate was 84.61 percent (55/65). Among all participants 12.7 percent did not “heard about Pradhan Mantri Jan Aushadhi Pariyojana Kendra”. Among all participants only 40 percent were not aware about Pradhan Mantri Jan Aushadhi Pariyojana Kendra situated in their area. Among all participants 72.73% aware about safe generic medicines, while among participant groups 60% of participating doctors, all nursing and pharmacy professionals and 72% of others accepted that generic medicines are safe as like branded medicines. A variation observed in respect of knowledge, and experience on generic medicines among participants. 40% (percent) of participating doctors did not believe in generic medicines and opted that the generic medicines are not safe as like branded medicines. Therefore, need for more training/awareness programmes on generic medicine arises. Need for building trust among healthcare professionals on generic medicines required.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Reference20 articles.

1. Vishwanath J. Availability, Affordability and Accessibility to Patented and Generic Medicines for Treating Life Threatening Diseases in India: An Assessment. Asian Journal of Pharmaceutical Reseach. 2016;6(3):145. doi.org/10.5958/2231-5691.2016.00021.6

2. Verma RK. Generic Medicines : Core Issues and Legal Mechanism. International Journal of Reviews and Research in Social Science Research. 2019;07(02):405–14. doi.org/10.5958/2454-2687.2019.00033.9

3. Minutes of the 71st Meeting of Drugs Technical Advisory Board held on 13th May, 2016 at CDSCO, HQ, FDA Bhawan, Kotla Road, New Delhi. Available on https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/common_download.jsp?num_id_pk=Nzcx

4. Message From the CEO BPPI. Available on http://janaushadhi.gov.in/mesgceo.aspx

5. Functions of CDSCO, DGHS Ministry of Health and Family Welfare. Available on https://cdsco.gov.in/opencms/opencms/en/About-us/Functions/

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3